hilar cholangiocarcinoma
Conditions
Interventions
regional lymphadenectomy group:regional lymphadenectomy
extended lymphadenectomy group:extended lymphadenectomy
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1) Patients >18 years and =80 years of age; 2) Preoperative imaging and laboratory examination diagnosed as hilar cholangiocarcinoma, biliary malignant tumor confirmed by intraoperative frozen and postoperative pathology; The resectability was assessed by preoperative imaging assessment; 3) Liver function Child-Turcotte-Pugh score A-B grade; 4) The residual liver volume is >30%; 5) ASA 1-4 level; 6) The written informed consent could be obtained by the patient and be able to complete the follow-up; 7) Female patients with gestational age need to be excluded from pregnancy; 8) There is no missing clinical data.
Exclusion criteria
Exclusion criteria: 1) Patients have significant heart, lung, brain and kidney dysfunction that affect the management of cholangiocarcinoma; 2) The patient has a history of other malignant tumors; 3) Liver function Child-Turcotte-Pugh score C; 4) ASA level 5-6 5) Pregnant or pregnant women who are breast feeding 6) The investigator determined that it is not suitable for the research 7) Patients with missing data or no follow-up after surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| survival;disease-free survival; | — |
Countries
China
Contacts
Public ContactFuyu Li
Department of Biliary Surgery, West China Hospital, Sichuan University
Outcome results
None listed